TRISTATE HOLD (00458) released its interim results, with profit attributable to shareholders reaching HK$23.543 million, a year-on-year increase of 1305.55%.
Lianya Group (00458) announced its interim results for the six months ended June 30, 2026, reporting a revenue of HK$1.543 billion, a decrease of 7.93% year-on-year; the profit attributable to equity shareholders reached HK$23.543 million, an increase of 1305.55% year-on-year; earnings per share were HK$0.086.
TRISTATE HOLD (00458) announced its interim results for the six months ending June 30, 2026, reporting revenue of HKD 1.543 billion, a year-on-year decrease of 7.93%; profit attributable to equity shareholders was HKD 23.543 million, a year-on-year increase of 1305.55%; earnings per share were HKD 0.086.
The announcement stated that in the first half of 2026, the group recorded a total gross profit of HKD 636 million (2025: HKD 687 million), with a gross profit margin of 41.2% (2025: 41.0%). The decline in gross profit was mainly due to a decrease in turnover. The gross profit margin in the garment business fell slightly compared to the same period last year, attributed to changes in the customer mix. The overall gross profit margin in the brand business, however, rose slightly compared to the same period last year. The groups overall gross profit margin remained stable.
Related Articles

Asymchem Laboratories (06821) granted 2.711 million restricted A-shares.

KAISA HEALTH (00876) announced its interim results, reporting a loss attributable to equity holders of HK$60.168 million, a year-on-year increase of approximately 6.77 times.

BFB HEALTH (00205) issues a profit warning, expecting a mid-term comprehensive profit of approximately HKD 8 million.
Asymchem Laboratories (06821) granted 2.711 million restricted A-shares.

KAISA HEALTH (00876) announced its interim results, reporting a loss attributable to equity holders of HK$60.168 million, a year-on-year increase of approximately 6.77 times.

BFB HEALTH (00205) issues a profit warning, expecting a mid-term comprehensive profit of approximately HKD 8 million.

RECOMMEND





